Home > Healthcare > Medical Devices > Implantable Devices > Bioimplants Market

Bioimplants Market Share

Report ID: GMI4035
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Bioimplants Market Share

The bioimplants industry is characterized by intense competition among key players striving to improve patient outcomes and address unmet medical needs. Inorganic growth initiatives such as partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Bioimplants Market Companies

Prominent players operating in the bioimplants industry include:

Abbott Laboratories
Arthrex inc.
aap Implantate AG
Biotronik SE & Co. KG
Cochlear Ltd.
DePuy Synthes (Johnson & Johnson)
Edwards Lifesciences Corporation
LifeNet Health
Medtronic plc
Organogenesis Inc.
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Bioimplants industry size was worth USD 132 billion in 2023 and is projected showcase 8.2% CAGR from 2024 to 2032, owing to the rising prevalence of chronic diseases and conditions, such as cardiovascular diseases, orthopedic disorders, and ophthalmic diseases.

The cardiovascular implants segment in the market recorded USD 47.4 billion in 2023 and is estimated to grow between 2024 and 2032, on account of the increasing prevalence of cardiovascular diseases and significant advancements in implants technology.

North America bioimplants industry was worth USD 48.6 billion in 2023 and is predicted to grow at 7.9% CAGR between 2024 and 2032, due to the presence of robust healthcare infrastructure, advanced technological innovations, and high healthcare expenditure.

Abbott Laboratories, Arthrex inc., aap Implantate AG, Biotronik SE & Co. KG, Cochlear Ltd., DePuy Synthes (Johnson & Johnson), Edwards Lifesciences Corporation, LifeNet Health, Medtronic plc, Organogenesis Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc. are some of the leading bioimplants companies worldwide.